drugset / Trial / NCT01944774

Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

NCT01944774

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to Evaluate the Efficacy, safety and pharmacokinetics of Intravenous Nemonoxacin Compared with Intravenous Moxifloxacin in Adult Patients with community-acquired pneumonia (CAP).

Timeline

Start
2013-03
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg Intravenous
Subject Nemonoxacin Small molecule 500 mg Intravenous
Subject Nemonoxacin Small molecule 650 mg Intravenous

Indications